Development and validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ)
Top Cited Papers
Open Access
- 1 April 2018
- Vol. 8 (4), e019413
- https://doi.org/10.1136/bmjopen-2017-019413
Abstract
Objective To develop and validate a new scale to assess treatment burden (the effort of looking after one's health) for patients with multimorbidity. Design Mixed-methods. Setting UK primary care. Participants Content of the Multimorbidity Treatment Burden Questionnaire (MTBQ) was based on a literature review and views from a patient and public involvement group. Face validity was assessed through cognitive interviews. The scale was piloted and the final version was tested in 1546 adults with multimorbidity (mean age 71 years) who took part in the 3D Study, a cluster randomised controlled trial. For each question, we examined the proportion of missing data and the distribution of responses. Factor analysis, Cronbach's alpha, Spearman's rank correlations and longitudinal regression assessed dimensional structure, internal consistency reliability, construct validity and responsiveness, respectively. We assessed interpretability by grouping the global MTBQ scores into zero and tertiles (>0) and comparing participant characteristics across these categories. Results Cognitive interviews found good acceptability and content validity. Factor analysis supported a one-factor solution. Cronbach's alpha was 0.83, indicating internal consistency reliability. The MTBQ score had a positive association with a comparator treatment burden scale (r(s) 0.58, P<0.0001) and with self-reported disease burden (r(s) 0.43, P<0.0001), and a negative association with quality of life (r(s)-0.36, P<0.0001) and self-rated health (r(s)-0.36, P<0.0001). Female participants, younger participants and participants with mental health conditions were more likely to have high treatment burden scores. Changes in MTBQ score over 9-month follow-up were associated, as expected, with changes in measures of quality of life (EuroQol five dimensions, five level questionnaire) and patient-centred care (Patient Assessment of Chronic Illness Care). Conclusion The MTBQ is a 10-item measure of treatment burden for patients with multimorbidity that has demonstrated good content validity, construct validity, reliability and responsiveness. It is a useful research tool for assessing the impact of interventions on treatment burden.Keywords
Funding Information
- Health Services and Delivery Research Programme
- Research Trainees Coordinating Centre
This publication has 19 references indexed in Scilit:
- Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative studyPatient Related Outcome Measures, 2012
- Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditionsBMC Medicine, 2012
- Illness representations in patients with multimorbid long-term conditions: Qualitative studyPsychology & Health, 2012
- Shifting priorities in multimorbidity: a longitudinal qualitative study of patient’s prioritization of multiple conditionsChronic Illness, 2011
- Epidemiology and impact of multimorbidity in primary care: a retrospective cohort studyBritish Journal of General Practice, 2011
- Seniors’ self-reported multimorbidity captured biopsychosocial factors not incorporated into two other data-based morbidity measuresJournal of Clinical Epidemiology, 2009
- Descriptions of Barriers to Self-Care by Persons with Comorbid Chronic DiseasesAnnals of Family Medicine, 2003
- Integrating response shift into health-related quality of life research: a theoretical modelSocial Science & Medicine, 1999
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- The Application of Electronic Computers to Factor AnalysisEducational and Psychological Measurement, 1960